TMDX Q1 2023 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$42M+161.7% YoY

Gross Profit

$29M69.2% margin

Operating Income

-$2M-5.0% margin

Net Income

-$3M-6.3% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+32.4%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$287M

Total Liabilities

$94M

Stockholders' Equity

$193M

Cash & Equivalents

$195M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$16M	+161.7%
Gross Profit	$29M	$12M	+137.7%
Operating Income	-$2M	-$9M	+77.7%
Net Income	-$3M	-$11M	+75.0%

Revenue Segments

Product

$34M82%

Service

$8M18%

Geographic Segments

UNITED STATES

$38M90%

Other Countries

$4M10%